Politico November 6, 2025
The deal could expand coverage and lower the price of GLP-1 medications for millions of Americans.
The Trump administration has struck a deal with drugmakers Eli Lilly and Novo Nordisk to offer their breakthrough weight-loss medications at steep discounts for certain Medicare and Medicaid patients, President Donald Trump announced at the White House on Thursday.
The deal also includes lower prices for GLP-1 drugs for Americans who use cash to buy them through a new government website, expected to debut next year, that will allow people to buy drugs directly from companies.
All told, the latest drug pricing deal between the Trump administration and drugmakers is poised to expand coverage and lower the price of the medications for millions of...
Today's Sponsors
Today's Sponsor